Indi Molecular, Inc.
Molecular binding platform technology for achieving ultra-high affinity ligand-receptor interactions with cooperative binding mechanisms
- Sector
- Biotech
- Headquarters
- CULVER CITY, CA
- Founded
- 2013
- Latest Form D
- $4.5M, Jun 2017
- Total capital
- $4.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4.5M
- 1 Form D · last Jun 2017
- 112 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 25 pending · first 2015
- Rank in peer group#179 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$4.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#179 · top 12%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Heather AgnewResearcherExecutive OfficerLinked by 1 patent
- James HeathResearcherDirectorLinked by 1 patent
- Albert LudererExecutive Officer, DirectorNamed in SEC Form D filings
- Andreas JurgeitDirectorNamed in SEC Form D filings
- Darren CaiDirectorNamed in SEC Form D filings
- Douglas FisherDirectorNamed in SEC Form D filings
Show all 7 people
- Leroy HoodDirectorNamed in SEC Form D filings
What it has protected
USPTO · 9 granted of 34- PendingCompositions, Delivery Systems, And Methods Useful In Tumor TherapyUSPTOApplication 18448781
- PendingCompositions, Imaging, And Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)USPTOApplication 18453159
- GrantedCompositions, Delivery Systems, And Methods Useful In Tumor TherapyUSPTOUS 11,766,414
Show all 34 patent records
- Compositions, Delivery Systems, And Methods Useful In Tumor TherapyJun 6, 2024 · Application 18448781Pending
- Compositions, Imaging, And Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)Feb 15, 2024 · Application 18453159Pending
- Compositions, Delivery Systems, And Methods Useful In Tumor TherapySep 26, 2023 · US 11,766,414Granted
- Compositions, Imaging, And Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)Aug 22, 2023 · US 11,733,246Granted
- Botulinum Neurotoxin-specific Capture Agents, Compositions, And Methods Of Using And MakingAug 15, 2023 · US 11,723,944Granted
- Theranostic Capture Agents, Compositions, And Methods Of Using And MakingMay 2, 2023 · US 11,638,764Granted
- Kras-specific Cyclic Peptides, Compositions, And Methods Of Using And MakingOct 13, 2022 · Application 17712930Pending
- Botulinum Neurotoxin-specific Capture Agents, Compositions, And Methods Of Using And MakingMay 18, 2021 · US 11,007,245Granted
- IL-17F-SPECIFIC Capture Agents, Compositions, And Methods Of Using And MakingMar 24, 2020 · US 10,598,671Granted
- Akt-specific Capture Agents, Compositions, And Methods Of Using And MakingMar 5, 2019 · US 10,221,214Granted
- Botulinum Neurotoxin-specific Capture Agents, Compositions, And Methods Of Using And MakingMar 13, 2018 · US 9,913,875Granted
- Vegf-specific Capture Agents, Compositions, And Methods Of Using And MakingDec 29, 2015 · US 9,221,889Granted
- Peptide Libraries With Non-canonical Amino AcidsApplication PCTUS2019059690Pending
- IL-17F And IL-17A-SPECIFIC Capture Agents, Compositions, And Methods Of Using And MakingApplication 62617944Pending
- Compositions For Detection, Inhibition And Imaging Of Indoleamine 2,3-DIOXYGENASE 1 (IDO1) And Methods Of Making And Using SameApplication PCTUS2017054546Pending
- IL-17F And IL-17A-SPECIFIC Capture Agents, Compositions, And Methods Of Using And MakingApplication 62520307Pending
- CD8-SPECIFIC Capture Agents, Compositions, And Methods Of Using And MakingApplication PCTUS2017025962Pending
- IL-17F-SPECIFIC Capture Agents, Compositions, And Methods Of Using And MakingApplication PCTUS2016042558Pending
- IL-17F-SPECIFIC Capture Agents, Compositions, And Methods Of Using And MakingApplication 62309756Pending
- Botulinum Neurotoxin-specific Capture Agents, Compositions, And Methods Of Using And MakingApplication PCTUS2016022693Pending
- C-met-specific Capture Agents, Compositions, And Methods Of Using And MakingApplication PCTUS2013069282Pending
- Vegf-specific Capture Agents, Compositions And Methods Of Using And MakingApplication PCTUS2012053388Pending
- C-met-specific Capture Agents, Compositions, And Methods Of Using And MakingApplication 14432283Pending
- Kras-specific Cyclic Peptides, Compositions, And Methods Of Using And MakingApplication PCTUS2022023318Pending
- Compositions, Delivery Systems, And Methods Useful In Tumor TherapyApplication PCTUS2021057880Pending
- Compositions, Imaging, And Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)Application PCTUS2021057877Pending
- Compositions, Imaging, And Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)Application 63256922Pending
- Compositions, Delivery Systems, And Methods Useful In Tumor TherapyApplication 63256885Pending
- KRAS-Specific Cyclic Peptides, Compositions, and Methods of Making and UsingApplication 63170261Pending
- Compositions, Imaging, And Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)Application 63109176Pending
- Compositions, Delivery Systems, And Methods Useful In Tumor TherapyApplication 63109186Pending
- Compositions And Methods Relating To Detection, Inhibition, And Imaging Of Indoleamine 2,3-DIOXYGENASE 1 (IDO1)Application PCTUS2020033858Pending
- Cross-linked Epitopes And Methods Of Use ThereofApplication PCTUS2020022452Pending
- Theranostic Capture Agents, Compositions, And Methods Of Using And MakingApplication PCTUS2019060571Pending
Related companies, and why
- Pulmatrix, Inc.Similar federal contract value in Biotech · null in contracts
- ImmunoVec, Inc.Similar federal contract value in Biotech · null in contracts
- Aurinia Pharmaceuticals Inc.Similar federal contract value in Biotech · null in contracts
- Annovis Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Cyrano Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Salarius Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .